Open AccessP1717: HEALTH‐RELATED QUALITY OF LIFE AND TOLERABILITY OF LONCASTUXIMAB TESIRINE IN HIGH‐RISK PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED IN A PHASE 2 CLINICAL TRIAL (LOTIS 2)
Author(s) -
Spira A.,
Liao L.,
Zhou X.,
Gnanasakthy A.,
Chen L.,
Ungar D.,
Yu E.,
Kilavuz T.,
Radford J.,
Hamadani M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849724.41434.b5
Subject(s) - tolerability , medicine , quality of life (healthcare) , visual analogue scale , refractory (planetary science) , clinical trial , oncology , lymphoma , adverse effect , physical therapy , nursing , physics , astrobiology